Is left atrial appendage occlusion a valuable treatment option for patients with atrial fibrillation and #breakthroughstroke despite anticoagulation therapy? @davidseiffge @boersma_lucas https://t.co/k9jxdatuDM
What to do with an ICH patient who bled while on AC for a mechanical heart valve? When and how to restart AC?
This is a cool study showing that the risk of bleeding complications far outweighs the risk of thromboembolism overall
Plus the risk of ICH is highest when IV heparin is given as a bridge to oral AC
https://t.co/8PRR7FWMks
In a trial from China involving 1412 patients with acute ischemic stroke presenting within 4.5 hours, the percentage who had an excellent functional outcome at 90 days was 79.5% with reteplase and 70.4% with alteplase. Full RAISE trial results: https://t.co/t0spgl8xPz
Case report: the evaluation of a 44-year-old man with a history of headache, dizziness, and imbalance and imaging that showed lacunar infarctions and bilateral white matter hyperintensities. https://t.co/QMtxfzZGpS
Between Enrich and Switch, exciting year for acute ICH trials! The balanced discussion section, with compare/contrast of effect sizes, eligibility criteria, and endpoints, is a treat to read. https://t.co/KYRgJo0UXw
Logging in after a while to feel out the reaction to ATRESIA. Twitter did not disappoint. Wonderful to have the data! Now, want the same for secondary prevention, including for very brief episodes of device-detected AF (30sec-6 min).